Pennsylvania · 2025-2026

SB 866

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Bill record: Open States bulk CSV (bills/votes) CC0-1.0

Summary AI-generated

Pennsylvania Senate Bill 866 proposes amendments to The Controlled Substance, Drug, Device and Cosmetic Act. The legislation further provides for schedules of controlled substances and mandates secure storage for xylazine. Additionally, the bill adds new provisions relating to medetomidine.

Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors + 3 cosponsors

Roll-call votes on this bill

QuestionChamberResultYeaNayOtherDateSource
FINAL PASSAGE upper pass 47 2 1 Jun 9, 2026 Open States bulk CSV (bills/votes) CC0-1.0
Committee vote (Appropriations): Re-Reported as Committed upper pass 22 0 0 Jun 8, 2026 Open States bulk CSV (bills/votes) CC0-1.0
Committee vote (Agriculture & Rural Affairs): Reported as Committed upper pass 11 0 0 Jun 2, 2026 Open States bulk CSV (bills/votes) CC0-1.0